These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18506357)

  • 21. Rituximab in refractory pemphigus vulgaris.
    Sorce M; Aricò M; Bongiorno MR
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of pemphigus.
    Tsuruta D; Ishii N; Hashimoto T
    Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment strategies for pemphigus vulgaris in Japan.
    Hashimoto T
    Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of pemphigus in pediatric patients.
    Gürcan H; Mabrouk D; Razzaque Ahmed A
    Minerva Pediatr; 2011 Aug; 63(4):279-91. PubMed ID: 21909064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory trials in chronic heart failure.
    Aukrust P; Yndestad A; Ueland T; Damås JK; Gullestad L
    Heart Fail Monit; 2006; 5(1):2-9. PubMed ID: 16547529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
    Frew JW; Martin LK; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):599-606. PubMed ID: 21925004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemphigus vulgaris: approach to treatment.
    Sinha AA; Hoffman MB; Janicke EC
    Eur J Dermatol; 2015 Apr; 25(2):103-13. PubMed ID: 25547117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemphigus vulgaris and vegetans.
    Becker BA; Gaspari AA
    Dermatol Clin; 1993 Jul; 11(3):429-52. PubMed ID: 8365030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemphigus.
    Ioannides D; Lazaridou E; Rigopoulos D
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1478-96. PubMed ID: 18637862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes].
    Göttfried I; Seeber A; Anegg B; Pirkhammer D; Rieger A; Stingl G; Volc-Platzer B
    Wien Klin Wochenschr; 1996 Nov; 108(22):705-16. PubMed ID: 9157716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recalcitrant pemphigus herpetiformis with high titer of immunoglobulin G antibody to desmoglein 1 and positive IgG antibody to desmocollin 3, elevating thymus and activation-regulated chemokine.
    Matsukura S; Takahashi K; Hirokado M; Ikezawa Y; Nakamura K; Fukuda S; Hashimoto T; Ikezawa Z; Aihara M; Kambara T
    Int J Dermatol; 2014 Aug; 53(8):1023-6. PubMed ID: 23432082
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral mucosal disease: pemphigus.
    Scully C; Mignogna M
    Br J Oral Maxillofac Surg; 2008 Jun; 46(4):272-7. PubMed ID: 17870218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of pemphigus].
    van Beek N; Zillikens D; Schmidt E
    Hautarzt; 2019 Apr; 70(4):243-253. PubMed ID: 30887081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A current review of juvenile pemphigus vulgaris: analysis of data on clinical outcomes.
    Asarch A; Gürcan HM; Ahmed AR
    Am J Clin Dermatol; 2010; 11(1):21-33. PubMed ID: 20000872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoadsorption in the treatment of pemphigus.
    Mlynek A; Meurer M
    Atheroscler Suppl; 2009 Dec; 10(5):107-9. PubMed ID: 20129386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seeking approval: present and future therapies for pemphigus vulgaris.
    Mao X; Payne AS
    Curr Opin Investig Drugs; 2008 May; 9(5):497-504. PubMed ID: 18465660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone.
    Nanda M; Nanda A; Al-Sabah H; Dvorak R; Alsaleh QA
    Int J Dermatol; 2007 Jul; 46(7):767-9. PubMed ID: 17614814
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on pemphigus treatment: present and future.
    Brownell I
    J Drugs Dermatol; 2007 Dec; 6(12):1243-5. PubMed ID: 18189067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of therapeutic plasma exchange in pemphigus vulgaris.
    Sagi L; Baum S; Gendelman V; Trau H; Barzilai A
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):82-6. PubMed ID: 20477926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.